Literature DB >> 30809820

Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon.

Bianca Lokhorst1, Leàn Rolfes1, Naomi T Jessurun1.   

Abstract

Entities:  

Keywords:  acenocoumarol; adverse drug reactions; cytochrome P450 enzymes; drug interactions; noscapine; phenprocoumon

Mesh：

Substances：

Year:  2019        PMID： 30809820      PMCID： PMC6475677          DOI： 10.1111/bcp.13887

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

Review 1.  Noscapine may increase the effect of warfarin.

Authors:  Staffan Ohlsson; Lennart Holm; Olle Myrberg; Anders Sundström; Qun-Ying Yue
Journal:  Br J Clin Pharmacol       Date:  2007-09-13       Impact factor: 4.335

2.  Warfarin-noscapine interaction: a series of four case reports.

Authors:  Maria Gabriella Scordo; Håkan Melhus; Elisabet Stjernberg; Anne Maria Edvardsson; Mia Wadelius
Journal:  Ann Pharmacother       Date:  2008-02-26       Impact factor: 3.154

Review 3.  Human P450 metabolism of warfarin.

Authors:  L S Kaminsky; Z Y Zhang
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

Review 4.  The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications.

Authors:  Padmashree C G Rida; Dillon LiVecche; Angela Ogden; Jun Zhou; Ritu Aneja
Journal:  Med Res Rev       Date:  2015-07-14       Impact factor: 12.944

5.  Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon.

Authors:  Bianca Lokhorst; Leàn Rolfes; Naomi T Jessurun
Journal:  Br J Clin Pharmacol       Date:  2019-02-26       Impact factor: 4.335

6.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

7.  Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction.

Authors:  Zhong-Ze Fang; Yan-Yan Zhang; Guang-Bo Ge; Hong Huo; Si-Cheng Liang; Ling Yang
Journal:  Br J Clin Pharmacol       Date:  2010-02       Impact factor: 4.335

8.  Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.

Authors:  Nan Zhang; Ryan P Seguin; Kent L Kunze; Yan-Yan Zhang; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2013-09-17       Impact factor: 3.922

9.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971
  9 in total
  3 in total

1.  Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon.

Authors:  Bianca Lokhorst; Leàn Rolfes; Naomi T Jessurun
Journal:  Br J Clin Pharmacol       Date:  2019-02-26       Impact factor: 4.335

2.  Assessment of Dry Heating, Water Rinsing, and Baking on Concentrations of the Opium Alkaloid Noscapine in Poppy Seeds.

Authors:  Shalaka A Shetge; Benjamin W Redan
Journal:  ACS Food Sci Technol       Date:  2022-02-17

Review 3.  Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches.

Authors:  Yuefei Jin; Wangquan Ji; Haiyan Yang; Shuaiyin Chen; Weiguo Zhang; Guangcai Duan
Journal:  Signal Transduct Target Ther       Date:  2020-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.